All (n = 51) | Glibenclamide (n = 23) | Acarbose (n = 28) | P value | |
---|---|---|---|---|
Gender (female, %) | 51.0% | 56.5% | 46.4% | 0.477 |
Age (years) | 53.7 ± 8.2 | 54.7 ± 8.3 | 52.8 ± 8.2 | 0.378 |
Disease duration (years) | 6.9 ± 4.6 | 6.0 ± 4.7 | 7.6 ± 4.5 | 0.106 |
BMI (kg/m2) | 25.6 ± 3.3 | 25.3 ± 3.8 | 25.9 ± 3.0 | 0.334 |
HbA1c (%) | 8.4 ± 1.2 | 8.6 ± 1.6 | 8.2 ± 0.8 | 0.691 |
Fasting plasma glucose (mmol/l) | 8.5 ± 2.3 | 9.0 ± 3.0 | 8.2 ± 1.3 | 0.538 |
DI30 | 41.1 ± 25.0 | 36.8 ± 19.1 | 44.7 ± 29.0 | 0.247 |
DI120 | 57.3 ± 28.6 | 51.2 ± 24.2 | 62.5 ± 31.4 | 0.289 |
HOMA-IR | 3.7 ± 2.9 | 4.7 ± 3.9 | 2.9 ± 1.5 | 0.316 |
MISI | 3.4 ± 1.8 | 3.2 ± 1.7 | 3.6 ± 1.8 | 0.321 |
HOMA-β (%) | 44.9 ± 40.4 | 52.3 ± 49.7 | 38.9 ± 30.4 | 0.248 |
Insulinogenic index30 (pmol/mmol) | 42.1 ± 63.4 | 35.0 ± 37.2 | 47.9 ± 79.0 | 0.416 |